Antibody data
- Antibody Data
- Antigen structure
- References [22]
- Comments [0]
- Validations
- Western blot [1]
- Immunoprecipitation [1]
- Immunohistochemistry [4]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 11344-1-AP - Provider product page
- Provider
- Proteintech Group
- Proper citation
- Proteintech Cat#11344-1-AP, RRID:AB_2232950
- Product name
- HDGF antibody
- Antibody type
- Polyclonal
- Description
- KD/KO validated HDGF antibody (Cat. #11344-1-AP) is a rabbit polyclonal antibody that shows reactivity with human and has been validated for the following applications: IHC, IP, WB,ELISA.
- Reactivity
- Human
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references Gint4.T-siHDGF chimera-capped mesoporous silica nanoparticles encapsulating temozolomide for synergistic glioblastoma therapy.
BLM promotes malignancy in PCa by inducing KRAS expression and RhoA suppression via its interaction with HDGF and activation of MAPK/ERK pathway.
Nucleophilic covalent ligand discovery for the cysteine redoxome.
Clinicopathological features and immunophenotype of Silva pattern system in endocervical adenocarcinoma.
NAP1L1 promotes the growth of colon cancer by activating HDGF/DDX5.
RNA-m6A modification of HDGF mediated by Mettl3 aggravates the progression of atherosclerosis by regulating macrophages polarization via energy metabolism reprogramming.
NAP1L1 Functions as a Tumor Promoter via Recruiting Hepatoma-Derived Growth Factor/c-Jun Signal in Hepatocellular Carcinoma.
NAP1L1 interacts with hepatoma-derived growth factor to recruit c-Jun inducing breast cancer growth.
LncRNA SNHG3 promotes cell proliferation and invasion through the miR-384/hepatoma-derived growth factor axis in breast cancer.
HDGF and PRKCA upregulation is associated with a poor prognosis in patients with lung adenocarcinoma.
Upregulation of miR‑95-3p inhibits growth of osteosarcoma by targeting HDGF.
Role of hepatoma-derived growth factor in promoting de novo lipogenesis and tumorigenesis in hepatocellular carcinoma.
Hepatoma-derived growth factor promotes growth and metastasis of hepatocellular carcinoma cells.
Downregulation of the expression of HDGF attenuates malignant biological behaviors of hilar cholangiocarcinoma cells.
Proteomic analysis of cell proliferation in a human hepatic cell line (HL-7702) induced by perfluorooctane sulfonate using iTRAQ.
High nuclear expression of HDGF correlates with disease progression and poor prognosis in human endometrial carcinoma.
Identification of hepatoma-derived growth factor as a potential prognostic and diagnostic marker for extrahepatic cholangiocarcinoma.
Upregulation of nucleus HDGF predicts poor prognostic outcome in patients with penile squamous cell carcinoma bypass VEGF-A and Ki-67.
Expression and clinical significance of hepatoma-derived growth factor as a prognostic factor in human hilar cholangiocarcinoma.
Increased expression of hepatoma-derived growth factor correlates with poor prognosis in human nasopharyngeal carcinoma.
Overexpressed HDGF as an independent prognostic factor is involved in poor prognosis in Chinese patients with liver cancer.
Identification of glia maturation factor beta as an independent prognostic predictor for serous ovarian cancer.
Fei H, Jin Y, Jiang N, Zhou Y, Wei N, Liu Y, Miao J, Zhang L, Li R, Zhang A, Du S
Biomaterials 2024 Apr;306:122479
Biomaterials 2024 Apr;306:122479
BLM promotes malignancy in PCa by inducing KRAS expression and RhoA suppression via its interaction with HDGF and activation of MAPK/ERK pathway.
Guo Y, Xu H, Huang M, Ruan Y
Journal of cell communication and signaling 2023 Sep;17(3):757-772
Journal of cell communication and signaling 2023 Sep;17(3):757-772
Nucleophilic covalent ligand discovery for the cysteine redoxome.
Fu L, Jung Y, Tian C, Ferreira RB, Cheng R, He F, Yang J, Carroll KS
Nature chemical biology 2023 Nov;19(11):1309-1319
Nature chemical biology 2023 Nov;19(11):1309-1319
Clinicopathological features and immunophenotype of Silva pattern system in endocervical adenocarcinoma.
Zeng C, Wu JK, Lu X
International journal of experimental pathology 2023 Jun;104(3):140-150
International journal of experimental pathology 2023 Jun;104(3):140-150
NAP1L1 promotes the growth of colon cancer by activating HDGF/DDX5.
Liang X, Tang Z, Zhang Y, Sun Y, Wang J
Acta biochimica et biophysica Sinica 2022 Sep 25;54(9):1234-1243
Acta biochimica et biophysica Sinica 2022 Sep 25;54(9):1234-1243
RNA-m6A modification of HDGF mediated by Mettl3 aggravates the progression of atherosclerosis by regulating macrophages polarization via energy metabolism reprogramming.
Zheng L, Chen X, Yin Q, Gu J, Chen J, Chen M, Zhang Y, Dong M, Jiang H, Yin N, Chen H, Li X
Biochemical and biophysical research communications 2022 Dec 20;635:120-127
Biochemical and biophysical research communications 2022 Dec 20;635:120-127
NAP1L1 Functions as a Tumor Promoter via Recruiting Hepatoma-Derived Growth Factor/c-Jun Signal in Hepatocellular Carcinoma.
Zhang YW, Chen Q, Li B, Li HY, Zhao XK, Xiao YY, Liu S, Zuo S
Frontiers in cell and developmental biology 2021;9:659680
Frontiers in cell and developmental biology 2021;9:659680
NAP1L1 interacts with hepatoma-derived growth factor to recruit c-Jun inducing breast cancer growth.
Liu S, Zhang Y, Cui S, Song D, Li B, Chen Q, Yao G, Gong B
Cancer cell international 2021 Nov 13;21(1):605
Cancer cell international 2021 Nov 13;21(1):605
LncRNA SNHG3 promotes cell proliferation and invasion through the miR-384/hepatoma-derived growth factor axis in breast cancer.
Ma Q, Qi X, Lin X, Li L, Chen L, Hu W
Human cell 2020 Jan;33(1):232-242
Human cell 2020 Jan;33(1):232-242
HDGF and PRKCA upregulation is associated with a poor prognosis in patients with lung adenocarcinoma.
Jiang H, Fu Q, Song X, Ge C, Li R, Li Z, Zeng B, Li C, Wang Y, Xue Y, Luo R, Fang W
Oncology letters 2019 Nov;18(5):4936-4946
Oncology letters 2019 Nov;18(5):4936-4946
Upregulation of miR‑95-3p inhibits growth of osteosarcoma by targeting HDGF.
Liu X, Ma W, Ma J, Xiao L, Hao D
Pathology, research and practice 2019 Aug;215(8):152492
Pathology, research and practice 2019 Aug;215(8):152492
Role of hepatoma-derived growth factor in promoting de novo lipogenesis and tumorigenesis in hepatocellular carcinoma.
Min X, Wen J, Zhao L, Wang K, Li Q, Huang G, Liu J, Zhao X
Molecular oncology 2018 Sep;12(9):1480-1497
Molecular oncology 2018 Sep;12(9):1480-1497
Hepatoma-derived growth factor promotes growth and metastasis of hepatocellular carcinoma cells.
Yang GY, Zhang AQ, Wang J, Li CH, Wang XQ, Pan K, Zhou C, Dong JH
Cell biochemistry and function 2016 Jun;34(4):274-85
Cell biochemistry and function 2016 Jun;34(4):274-85
Downregulation of the expression of HDGF attenuates malignant biological behaviors of hilar cholangiocarcinoma cells.
Liu Y, Sun J, Yang G, Liu Z, Guo S, Zhao R, Xu K, Wu X, Zhang Z
Molecular medicine reports 2015 Sep;12(3):4713-4719
Molecular medicine reports 2015 Sep;12(3):4713-4719
Proteomic analysis of cell proliferation in a human hepatic cell line (HL-7702) induced by perfluorooctane sulfonate using iTRAQ.
Cui R, Zhang H, Guo X, Cui Q, Wang J, Dai J
Journal of hazardous materials 2015 Dec 15;299:361-70
Journal of hazardous materials 2015 Dec 15;299:361-70
High nuclear expression of HDGF correlates with disease progression and poor prognosis in human endometrial carcinoma.
Wang L, Jiang Q, Hua S, Zhao M, Wu Q, Fu Q, Fang W, Guo S
Disease markers 2014;2014:298795
Disease markers 2014;2014:298795
Identification of hepatoma-derived growth factor as a potential prognostic and diagnostic marker for extrahepatic cholangiocarcinoma.
Han Y, Zhang W, Liu Y
World journal of surgery 2013 Oct;37(10):2419-27
World journal of surgery 2013 Oct;37(10):2419-27
Upregulation of nucleus HDGF predicts poor prognostic outcome in patients with penile squamous cell carcinoma bypass VEGF-A and Ki-67.
Li D, Han Z, Liu J, Zhang X, Ren J, Yan L, Liu H, Xu Z
Medical oncology (Northwood, London, England) 2013 Dec;30(4):702
Medical oncology (Northwood, London, England) 2013 Dec;30(4):702
Expression and clinical significance of hepatoma-derived growth factor as a prognostic factor in human hilar cholangiocarcinoma.
Liu YF, Zhao R, Guo S, Wang XQ, Lian PL, Chen YG, Xu KS
Annals of surgical oncology 2011 Mar;18(3):872-9
Annals of surgical oncology 2011 Mar;18(3):872-9
Increased expression of hepatoma-derived growth factor correlates with poor prognosis in human nasopharyngeal carcinoma.
Wang S, Fang W
Histopathology 2011 Jan;58(2):217-24
Histopathology 2011 Jan;58(2):217-24
Overexpressed HDGF as an independent prognostic factor is involved in poor prognosis in Chinese patients with liver cancer.
Zhou Y, Zhou N, Fang W, Huo J
Diagnostic pathology 2010 Sep 16;5:58
Diagnostic pathology 2010 Sep 16;5:58
Identification of glia maturation factor beta as an independent prognostic predictor for serous ovarian cancer.
Li YL, Ye F, Cheng XD, Hu Y, Zhou CY, Lü WG, Xie X
European journal of cancer (Oxford, England : 1990) 2010 Jul;46(11):2104-18
European journal of cancer (Oxford, England : 1990) 2010 Jul;46(11):2104-18
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- HeLa cells were subjected to SDS PAGE followed by western blot with 11344-1-AP(HDGF antibody) at dilution of 1:2000
- Sample type
- cell line
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- IP Result of anti-HDGF (IP:11344-1-AP, 3ug; Detection:11344-1-AP 1:1000) with HepG2 cells lysate 3000ug.
- Sample type
- cell line
Supportive validation
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- Immunohistochemical of paraffin-embedded human lung cancer using 11344-1-AP(HDGF antibody) at dilution of 1:100 (under 10x lens)
- Sample type
- tissue
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- The HDGF antibody from Proteintech is a rabbit polyclonal antibody to a recombinant protein of human HDGF. This antibody recognizes human,mouse,rat antigen. The HDGF antibody has been validated for the following applications: ELISA, IP, WB, IHC analysis.
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- Immunohistochemical of paraffin-embedded human ovary tumor using 11344-1-AP(HDGF antibody) at dilution of 1:100 (under 10x lens)
- Sample type
- tissue
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- Immunohistochemical of paraffin-embedded human ovary tumor using 11344-1-AP(HDGF antibody) at dilution of 1:100 (under 40x lens)
- Sample type
- tissue